# US 2025/0145580 A1 · An improved process for the preparation of ferric maltol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0145580 A1
- Document ID: US20250145580A1
- Status: Published application
- Kind: A1
- Application number: 18/693,964
- Filed: 2022-05-26
- Published: 2025-05-08
- Earliest claimed: 2021-09-21
- Assignees: Rk Pharma Inc.; Apicore Pharmaceuticals Private Limited
- Applicants: RK Pharma Inc.; Apicore Pharmaceuticals Private Limited
- Inventors: Ravishanker KOVI; Jayaraman KANNAPPAN; Hemant MANDE; Srikrishna APAR
- Web page: https://patentgrep.com/patent/US20250145580A1

## CPC

- C07D 309/40: Oxygen atoms attached in positions 3 and 4, e.g. maltol
- A61K 31/357: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a new and improved method of forming Ferric maltol by reacting a Maltol in an organic alkaline solution/slurry with a non-carboxylate iron salt in an organic solvent. The present invention also provides an improved process for the preparation of polymorphic form alpha of ferric maltol. The present invention further provides novel polymorphic forms RK1, RK2, RK3, RK4, RK5, RK6 and RK7 of Ferric maltol with a characteristic XRPD Patterns respectively and process for their preparation thereof.

## Claims

### Claim at position 1

1-6. (canceled)

### Claim 7

A Polymorphic form RK1 of Ferric maltol characterized by X-ray powder diffraction pattern comprising a characteristic crystalline peaks expressed in degrees 2-theta at 5.4, 11.5, 12.5, 16.0, 16.4, 23.4 and 24.2±0.2°

### Claim 8 (depends on 7)

An improved process for the preparation of polymorphic form RK1 of ferric maltol as claimed in claim 7, comprising the steps of:
a) providing a solution of ferric maltol in chloroform or mixture of chloroform and organic solvent;
b) addition of anti-solvent to the solution obtained in step a);
c) isolation of polymorphic form RK1 of Ferric maltol.

### Claim 9 (depends on 8)

An improved process as claimed in claim 8, wherein organic solvent used in step a) is ethanol and anti-solvent used in step b) is MTBE or ethyl acetate.

### Claim 10

A Polymorphic Form RK2 of Ferric maltol characterized by X-ray powder diffraction pattern comprising characteristic crystalline peaks expressed in degrees 2-theta at 6.8, 10.6, 12.2, 13.8, 15.2, 15.8, 22.9, 24.2±0.2°

### Claim 11 (depends on 10)

An improved process for the preparation of polymorphic form RK2 of ferric maltol as claimed in claim 10, comprising:
a) drying the polymorphic form RK2 of ferric maltol between 100° C.-150° C. for 3-4 hours.

### Claim 12

A polymorphic form RK3 of Ferric maltol characterized by X-ray powder diffraction pattern comprising characteristic crystalline peaks expressed in degrees 2-theta at 11.5, 14.2, 18.3, 23.3, 24.9±0.2°.

### Claim 13 (depends on 12)

An improved process for the preparation of polymorphic form RK3 of Ferric maltol as claimed in claim 12, comprising the steps of:
a) Slurring the Ferric maltol in Dichloromethane at room temperature;
b) Adding Methyl tertiary butyl ether into the slurry mass at room temperature to obtain polymorphic form RK3 of Ferric maltol

### Claim 14

A polymorphic form RK4 of Ferric maltol characterized by X-ray powder diffraction pattern comprising characteristic crystalline peaks expressed in degrees 2-theta at 9.1, 11.9, 13.6, 17.1, 22.0 and 22.7±0.2°.

### Claim 15 (depends on 14)

An improved process for the preparation of polymorphic form RK4 of Ferric maltol as claimed in claim 14, comprising the steps of:
a) Dissolving Ferric maltol in Dichloromethane or Chloroform at room temperature;
b) Filtering the solution to remove undissolved particulate;
c) evaporating the solvent from the filtrate on rotary evaporator to obtain Polymorphic form Alpha of ferric maltol;
d) Adding Chlorobenzene and stirring at room temperature for 5-10 minutes;
e) Adding Methyl tertiary butyl ether (MTBE) into the slurry mass at room temperature to obtain polymorphic form RK4 of Ferric maltol.

### Claim 16

A polymorphic form RK5 of Ferric maltol characterized by X-ray powder diffraction pattern comprising characteristic crystalline peaks expressed in degrees 2-theta at 9.6, 14.5, 16.3, 19.3, 22.0 and 22.2±0.2°.

### Claim 17 (depends on 16)

An improved process for the preparation of polymorphic form RK5 of Ferric maltol as claimed in claim 16, comprising the steps of:
a) Slurring Polymorphic Form Alpha or RK2 of Ferric maltol in Carbon tetrachloride (CCl4) at room temperature.
b) Adding Methyl tertiary butyl ether (MTBE) into the slurry mass at room temperature to obtain polymorphic form RK5 of Ferric maltol.

### Claim 18

A polymorphic Form RK6 of Ferric maltol characterized by powder X-ray diffraction pattern comprising a characteristic crystalline peak expressed in degrees 2-theta at 6.6±0.2°, and two or more further peaks expressed in degrees 2-theta selected from 11.6, 13.3, 16.4 and 23.9±0.2° 2θ.

### Claim 19

(canceled)

### Claim 20 (depends on 18)

An improved process for the preparation of polymorphic form RK6 of Ferric maltol as claimed in claim 18 comprising the steps of:
a) Dissolving the Polymorphic Form Alpha or RK2 of Ferric maltol in Acetic acid at room temperature;
b) Filtering the solution to remove undissolved particulate;
c) Adding the filtrate slowly into Methyl tertiary butyl ether (MTBE) at room temperature to obtain polymorphic form RK6 of Ferric maltol.

### Claim 21

A polymorphic form RK7 of Ferric maltol characterized by X-ray powder diffraction pattern comprising characteristic crystalline peaks expressed in degrees 2-theta at 5.1, 10.3, 13.0, 15.0, 18.0, and 23.8±0.2°.

### Claim 22 (depends on 21)

An improved process for the preparation of polymorphic form RK7 of Ferric maltol as claimed in claim 21, comprising the steps of:
a) Slurring/dissolving the Polymorphic Form Alpha or RK2 of Ferric maltol in Propionic acid at room temperature;
b) Filtering the solution to remove undissolved particulate;
c) Adding the filtrate slowly into Methyl tertiary butyl ether (MTBE) at room temperature to obtain polymorphic form RK7 of Ferric maltol.
